Biology of the Neonate · 2009 · 27 citations · 10 references
PharmacyPharmacologyPharmacotherapyNeonatologyPediatric Clinical PharmacologyPediatric TherapeuticsAcute Respiratory Distress SyndromeNeonatal Drug TherapyNeonatal PharmacotherapyRespiratory Distress In NewbornsRespiratory Distress SyndromeSurfactantsBlood PressureCerebral Blood Flow AlterationsCerebral Blood Flow RegulationFluid Bolus TherapyPediatric Respiratory Distress SyndromePulmonary Surfactant AdministrationPulmonary Surfactant TherapySurfactant Use
Fifteen preterm infants suffering from respiratory distress syndrome were randomly allocated to receive either high-dose (200 mg/kg) or low-dose (100 mg/kg) surfactant treatment. Retreatments were done with the low dose. Blood pressure, blood gases and cerebral blood flow velocities were determined before and after 24 bolus instillations. With the high dose mean blood pressure and mean cerebral blood flow velocity dropped significantly. With the low dose only mean cerebral blood flow velocity decreased; the course was unrelated to blood pressure or PCO2 fluctuations. The mechanisms leading to the observed circulatory changes after surfactant instillation remain unclear.
10
Prophylactic Treatment of Very Premature Infants with Human Surfactant
T. Allen Merritt, Mikko Hallman, Barry T. Bloom et al. · New England Journal of Medicine · 1986 · 254 citations
Medicine, Child Health, Pediatrics +13